Merck (MRK) Tops Q1 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
April 25, 2024 6:47 AM EDTMerck (NYSE: MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked its outlook for the fiscal year 2024.
For Q1 2024, Merck reported earnings per share (EPS) at $2.07, surpassing analyst expectations of $1.93. The companys revenue for the quarter was $15.8 billion,... More
Merck (MRK) call put ratio 2.6 calls to 1 put into quarter results and outlook
April 24, 2024 10:11 AM EDTMerck (NYSE: MRK) April weekly call option implied volatility is at 49, May is at 21; compared to its 52-week range of 16 to 26 into the expected release of quarter results before the bell on April 25.
... More